Ken Griffin Sensus Healthcare, Inc. Transaction History
Citadel Advisors LLC
- $559 Billion
- Q4 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Sensus Healthcare, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 3,800 shares of SRTS stock, worth $20,938. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,800
Previous 2,100
80.95%
Holding current value
$20,938
Previous $12,000
116.67%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding SRTS
# of Institutions
69Shares Held
4.6MCall Options Held
29.5KPut Options Held
800-
Vanguard Group Inc Valley Forge, PA740KShares$4.08 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny431KShares$2.37 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX379KShares$2.09 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA348KShares$1.92 Million0.01% of portfolio
-
Morgan Stanley New York, NY249KShares$1.37 Million0.0% of portfolio
About Sensus Healthcare, Inc.
- Ticker SRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,556,000
- Market Cap $91.2M
- Description
- Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provide...